American Stock Exchange, LLC v. Mopex, Inc.

215 F.R.D. 87, 2002 U.S. Dist. LEXIS 23924, 2002 WL 31812680
District Court, S.D. New York·Decided December 12, 2002·No. No. 00 Civ. 5943 SAS·Published·Cited by 67 cases

Opinion

OPINION AND ORDER

SCHEINDLIN, District Judge.

Mopex, Inc; (“Mopex”) has filed objections to the Report and Recommendations of United States Magistrate Judge Michael Dolinger (“R & R”), dated July 25, 2002, which recommends that the American Stock Exchange LLC’s (the “AMEX”) motion to preclude Mopex from asserting that the AMEX infringed claim 34 of Mopex’s United States Patent No. 6,088,685 (the ’685 patent’) be granted. I have duly considered Mopex’s objections. For the reasons set forth below, Mopex’s objections are denied, and Judge Dolinger’s R & R is accepted and adopted in full.

I. GENERAL BACKGROUND

The AMEX filed' the instant lawsuit against Mopex on August 10, 2000, seeking a declaratory judgment of non-infringement or invalidity of Mopex’s ’685 patent, which describes certain processes for creating investment products, known as exchange-traded funds. See Complaint (“Compl.”) at 1HI14, 15. On September 15, 2000, defendant filed an answer and counterclaim in this Court, alleging that the AMEX had infringed the ’685 patent, but not specifying which [89]*89aspects of the patent had been infringed. See Counterclaim at If13.

Throughout the course of fact discovery, the AMEX aggressively sought to obtain full disclosure of Mopex’s case, including identification of which patent claims Mopex was contending had been infringed. See, e.g., 11/10/00 Plaintiffs First Notice of Deposition of Defendant, Ex. B to Declaration of Paul S. Grossman, Esq., attorney for plaintiff (“Grossman Dee.”), at 1111 (requesting “[t]he full and complete factual basis for Mopex’s claim that [the] AMEX has infringed the ’685 patent”); 1/9/01 Deposition of Kenneth Kiron, president of Mopex (“Kiron Dep.”), Ex. D to Grossman Dec., at 43-46 (asking deponent to identify which claims of the ’685 patent have been asserted by Mopex against the AMEX); 7/11/01 Plaintiffs Second Set of Interrogatories to Defendant, Ex. E to Grossman Dec., at 1fH 1, 2 (asking Mopex to identify “the claims of the ’685 patent which Mopex alleges to be infringed”); 8/7/01 Plaintiffs First Requests for Admissions, Ex. G to Grossman Dec., at HH 7,10,15 (asking Mopex to admit that it “does not assert in this action that the listing and trading on the AMEX of [the accused investment products] infringes any independent claim of the ’685 patent other than claims 2,13, 24”); 1/18/02 Deposition of Clifford J. Weber, a senior officer at the AMEX (‘Weber Dep.”), Ex. J to Gross-man Dec., at 567-68 (asking Mopex’s attorney, after he questioned an AMEX witness about claim 34, whether it was Mopex’s position that the AMEX was infringing claim 34).

In each of Mopex’s responses to the AMEX’s discovery requests, Mopex identified only independent claims 2, 13, and 24, but noted that it was continuing to investigate the AMEX’s infringement and would update its responses when it received additional information. See, e.g., Kiron Dep. at 45^16 (“Right now as of today we’re focusing on independent claim 2, independent claim 13 and independent claim 24 and various dependent claims that are linked to the independent claims.”); 8/10/01 Defendant’s Answers to Plaintiffs Second Set of Interrogatories, Ex. F to Grossman Dec., at 11H 1, 2 (identifying only independent claims 2 and 13 and various dependent claims and promising to update its response upon receipt of additional information);1 9/17/01 Defendant’s Responses to Plaintiffs First Requests for Admissions, Ex. H to Grossman Dec., at HIT 7,10,15 (failing to identify claim 34 and promising to supplement its responses after the deposition of Cliff Weber, plaintiffs designated Rule 30(b)(6) witness).

One month after the conclusion of fact discovery, and only weeks before the scheduled exchange of expert witness reports, Mopex announced, for the first time, that it was contending that the AMEX had infringed claim 34. See Defendant’s Supplemental Answers to Plaintiffs Second Set of Interrogatories, Ex. K to Grossman Dee., at ITU 1, 2 (amending its answers to the AMEX’s interrogatories by identifying claim 34 as infringed).

On April 6, 2002, the parties exchanged expert reports. Mopex’s expert, Mr. C. Michael Carty, opined in his report that the AMEX was infringing claim 34. See R & R at 11. In response, the AMEX’s infringement expert, Mr. Gary C. Gastineau, issued a report, in which he opined, for the first time, on claim 34, acknowledging that he had not addressed the claim in his prior report because he was “unaware Mopex intended to assert the claim in the litigation” and that he was limited in his ability to now address the claim because the AMEX had taken no discovery specific to claim 34. See id.

II. PROCEDURAL HISTORY

On May 6, 2002, the AMEX moved to preclude Mopex from asserting that claim 34 of the ’685 patent was being infringed by the AMEX because Mopex had failed, until well after the completion of fact discovery, to identify claim 34. On May 13, 2002, this Court referred the AMEX’s motion to Magistrate Judge Dolinger for a report and recommendation. On July 25, 2002, Judge Doling-er issued an R & R, finding that Mopex’s inexcusable delay had “plainly and unfairly prejudiced the AMEX’s trial preparation” [90]*90and recommending that the AMEX’s motion to preclude be granted. See R & R at 3.

On August 7, 2002, Mopex filed the instant objections to Judge Dolinger’s conclusions that: (1) Mopex’s assertion of claim 34 unfairly prejudices the AMEX’s trial preparation; and (2) Mopex unjustifiably delayed in supplementing its interrogatory answers pursuant to Fed.R.Civ.P. 26(e)(2). See Mopex, Inc.’s Objections to Magistrate Judge Doling-er’s Report and Recommendations (“Obj.”) at 1.

III. FACTS

The Court incorporates by reference the detailed facts set forth in the R & R and makes the following additions: On January 26, 2001, the AMEX received two legal opinions in which its counsel opined that every claim of the ’685 patent, including claim 34, is invalid under 35 U.S.C. § 112, H1. See 1/16/01 Letter to Teri Nelson Jacoby, Office of General Counsel, National Association of Securities Dealers, Inc., from Lawrence Kolodney, Ex. B to Obj.; 1/16/01 Letter to Jacoby from Kolodney, Ex. C to Obj. On February 7, 2001, the AMEX received two additional opinions regarding the non-infringement of all of the claims of the ’685 patent. See 2/7/01 Letter to Jacoby from Kolodney, Ex. D to Obj.; 2/7/01 Letter to Jacoby from Kolodney, Ex. E to Obj.

IV. STANDARD OF REVIEW

“[A] judge may designate a magistrate to hear and determine any pretrial matter pending before the court,” except for certain enumerated dispositive motions. See 28 U.S.C. § 636(b)(1)(A); see also Fed.R.Civ.P. 72(b) (referring to dispositive motions as those “dispositive of a claim or defense of a party”).

Free access — add to your briefcase to read the full text and ask questions with AI

American Stock Exchange, LLC v. Mopex, Inc., 215 F.R.D. 87, 2002 U.S. Dist. LEXIS 23924, 2002 WL 31812680 (S.D.N.Y. 2002).

215 F.R.D. 87 (American Stock Exchange, LLC v. Mopex, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related